Clinical and Biological Significance of Never in Mitosis Gene A-Related Kinase 6 (NEK6) Expression in Hepatic Cell Cancer

被引:34
作者
Cao, Xiaolei [2 ]
Xia, Yunfei [1 ]
Yang, Junling [1 ]
Jiang, Jinxia [1 ]
Chen, Li [2 ]
Ni, Runzhou [1 ]
Li, Liren [1 ]
Gu, Zhifeng [1 ]
机构
[1] Nantong Univ, Dept Internal Med, Affiliated Hosp, Coll Med, Nantong 226001, Jiangsu, Peoples R China
[2] Nantong Univ, Dept Pathol, Coll Med, Nantong 226001, Jiangsu, Peoples R China
关键词
Human hepatocellular carcinoma (HCC); Nek6; Ki-67; Prognosis; PROTEIN-KINASES; PIN1;
D O I
10.1007/s12253-011-9429-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nek6 is a cell cycle regulatory gene, which can control cell proliferation and survival. Recent studies suggested that desregulation of Nek6 expression plays a key role in oncogenesis. This study was aimed to investigate the potential roles of Nek6 in hepatocellular carcinoma (HCC) development. Immunohistochemistry and Western blot analysis was performed for Nek6 in 80 hepatocellular carcinoma samples. The data were correlated with clinicopathological features. The univariate and multivariate survival analyses were performed to determine the prognostic significance of Nek6 in HCC. In addition, Nek6 expression vector was used to detect its role in cell cycle control. Nek6 was overexpressed in hepatocellular carcinoma as compared with the adjacent normal tissue. High expression of Nek6 was associated with histological grade and the level of alpha fetal protein, and Nek6 was positively correlated with proliferation marker Ki-67. Univariate analysis showed that Nek6 expression was associated with poor prognosis. Multivariate analysis indicated that Nek6 and Ki-67 protein expression was an independent prognostic marker for HCC. While in vitro, following release from serum starvation of HuH7 HCC cell, the expression of Nek6 was upregulated. Overexpression Nek6 in Huh7 cell could promote the cell cycle. In conclusion, Nek6 is involved in the pathogenesis of hepatocellular carcinoma. It may be a favorable independent poor prognostic parameter for hepatocellular carcinoma.
引用
收藏
页码:201 / 207
页数:7
相关论文
共 29 条
[1]   Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 [J].
Ahmed, Shahana ;
Thomas, Gilles ;
Ghoussaini, Maya ;
Healey, Catherine S. ;
Humphreys, Manjeet K. ;
Platte, Radka ;
Morrison, Jonathan ;
Maranian, Melanie ;
Pooley, Karen A. ;
Luben, Robert ;
Eccles, Diana ;
Evans, D. Gareth ;
Fletcher, Olivia ;
Johnson, Nichola ;
Silva, Isabel dos Santos ;
Peto, Julian ;
Stratton, Michael R. ;
Rahman, Nazneen ;
Jacobs, Kevin ;
Prentice, Ross ;
Anderson, Garnet L. ;
Rajkovic, Aleksandar ;
Curb, J. David ;
Ziegler, Regina G. ;
Berg, Christine D. ;
Buys, Saundra S. ;
McCarty, Catherine A. ;
Feigelson, Heather Spencer ;
Calle, Eugenia E. ;
Thun, Michael J. ;
Diver, W. Ryan ;
Bojesen, Stig ;
Nordestgaard, Borge G. ;
Flyger, Henrik ;
Doerk, Thilo ;
Schuermann, Peter ;
Hillemanns, Peter ;
Karstens, Johann H. ;
Bogdanova, Natalia V. ;
Antonenkova, Natalia N. ;
Zalutsky, Iosif V. ;
Bermisheva, Marina ;
Fedorova, Sardana ;
Khusnutdinova, Elza ;
Kang, Daehee ;
Yoo, Keun-Young ;
Noh, Dong Young ;
Ahn, Sei-Hyun ;
Devilee, Peter ;
van Asperen, Christi J. .
NATURE GENETICS, 2009, 41 (05) :585-590
[2]   Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005 [J].
Altekruse, Sean F. ;
McGlynn, Katherine A. ;
Reichman, Marsha E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) :1485-1491
[3]   A mitotic cascade of NIMA family kinases - Nercc1/Nek9 activates the Nek6 and Nek7 kinases [J].
Belham, C ;
Roig, J ;
Caldwell, JA ;
Aoyama, Y ;
Kemp, BE ;
Comb, M ;
Avruch, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (37) :34897-34909
[4]   Primary liver cancer:: Worldwide incidence and trends [J].
Bosch, FX ;
Ribes, J ;
Díaz, M ;
Cléries, R .
GASTROENTEROLOGY, 2004, 127 (05) :S5-S16
[5]   Interaction of Pin1 with Nek6 and characterization of their expression correlation in Chinese hepatocellular carcinoma patients [J].
Chen, J ;
Li, L ;
Zhang, YY ;
Yang, HR ;
Wei, YH ;
Zhang, L ;
Liu, XH ;
Yu, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 341 (04) :1059-1065
[6]  
Curado M.P., 2007, IARC Scientific Publication, V160
[7]   Targeting cell cycle kinases for cancer therapy [J].
de Carcer, Guillermo ;
Perez de Castro, Ignacio ;
Malumbres, Marcos .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (09) :969-985
[8]   Hepatitis B and Hepatocellular Carcinoma [J].
Di Bisceglie, Adrian M. .
HEPATOLOGY, 2009, 49 (05) :S56-S60
[9]   Issues in screening and surveillance for hepatocellular carcinoma [J].
Di Bisceglie, AM .
GASTROENTEROLOGY, 2004, 127 (05) :S104-S107
[10]   Cyclin g1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma [J].
Gramantieri, Laura ;
Ferracin, Manuela ;
Fornari, Francesca ;
Veronese, Airtgelo ;
Sabbioni, Silvia ;
Liu, Chang-Gong ;
Calin, George A. ;
Giovannini, Catia ;
Ferrazzi, Eros ;
Grazi, Gian Luca ;
Croce, Carlo M. ;
Bolondi, Luigi ;
Negrini, Massimo .
CANCER RESEARCH, 2007, 67 (13) :6092-6099